ACIDEX ADVANCE

Brand name authorized in: United Kingdom

Active ingredients

The drug ACIDEX ADVANCE contains a combination of these active pharmaceutical ingredients (APIs):

1 Alginic acid
UNII C269C4G2ZQ - SODIUM ALGINATE

Alginic acid is a polysaccharide distributed widely in the cell walls of brown algae which is hydrophilic and forms a viscous gum when hydrated. Its salts with metals such as sodium and calcium are known as alginates. It is a significant component of the biofilms produced by the bacterium Pseudomonas aeruginosa, a major pathogen found in the lungs of some people who have cystic fibrosis. The biofilm and P. aeruginosa have a high resistance to antibiotics and are susceptible to inhibition by macrophages. Its colour ranges from white to yellowish-brown. It is sold in filamentous, granular or powdered forms.

Read about Alginic acid
2 Potassium bicarbonate
UNII HM5Z15LEBN - POTASSIUM BICARBONATE
Read about Potassium bicarbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Alginic acid
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Discover more medicines within A02BX13

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 334958, 334964, 334968, 334969